Doctor profile · Federal record

Dr. Joseph Moore, MD

Medical Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Hematology (Internal Medicine) Physician · Wichita, KS

  • NPI 1750777959
  • Accepts Medicare
  • MIPS 67.4 / 100 · 2023
  • 11 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
3243 E Murdock St Ste 300
Wichita, KS 672083006
(316) 262-4467
Additional location
5323 Harry Hines Blvd
Dallas, TX 753907201
(214) 590-8000
Mailing address
818 N Emporia St Ste 403
Wichita, KS 672143728

Credentials & registration

NPPES · NUCC
NPI registered
April 2015 — 11 yrs on file
Profile last updated
June 1, 2021
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Kansas #04-44444

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750777959. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
294,015
Distinct HCPCS
10
Medicare allowed
$4,466,630
HCPCS Description Services Patients Avg allowed
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 43,080 40 $0
J1439 Injection, ferric carboxymaltose, 1 mg 32,250 33 $1
J0185 Injection, aprepitant, 1 mg 29,380 112 $2
J9263 Injection, oxaliplatin, 0.5 mg 24,700 34 $0
J9271 Injection, pembrolizumab, 1 mg 21,400 47 $54
J1627 Injection, granisetron, extended-release, 0.1 mg 15,600 85 $6
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 15,395 24 $3
J9299 Injection, nivolumab, 1 mg 14,780 16 $30
J0897 Injection, denosumab, 1 mg 7,380 55 $24
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 7,140 12 $0

In context: peer comparison

Among 1 peers in this city , average services per provider: 2,882. This provider delivers 102× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$11,869
Transactions
146
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
BeiGene USA, Inc. 1 $2,275.00
PFIZER INC. 25 $1,940.81
TAIHO ONCOLOGY, INC. 2 $1,580.64
Daiichi Sankyo Inc. 5 $1,469.32
AstraZeneca Pharmaceuticals LP 18 $995.30
ABBVIE INC. 25 $344.39
EMD Serono, Inc. 15 $246.15
Janssen Biotech, Inc. 11 $231.44
Novartis Pharmaceuticals Corporation 11 $192.54
Genentech USA, Inc. 9 $147.82
GENZYME CORPORATION 5 $107.37
Merck Sharp & Dohme LLC 5 $105.72
GlaxoSmithKline, LLC. 5 $102.10
Lilly USA, LLC 5 $101.67
Exelixis Inc. 4 $95.13

By nature of payment

Consulting Fee
$5,748
Food and Beverage
$4,502
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$1,620

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
994
Patients
323
Total drug cost
$94,868
Drug Type Claims Patients Total cost
Letrozole Generic 127 39 $5,204
Acyclovir Generic 116 22 $1,951
Ondansetron Odt (Ondansetron) Brand 100 71 $4,220
Prednisone Generic 97 30 $724
Eliquis (Apixaban) Brand 72 14 $44,656
Levofloxacin Generic 65 35 $942
Potassium Chloride Generic 54 20 $1,150
Levothyroxine Sodium Generic 52 0 $401
Dexamethasone Generic 51 31 $976
Pantoprazole Sodium Generic 51 17 $516

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Joseph Moore's medical specialty?
Dr. Joseph Moore practices Medical Oncology Physician in Wichita, KS.
Where does Dr. Joseph Moore practice?
Dr. Joseph Moore practices at 3243 E Murdock St Ste 300, Wichita, KS 672083006. Office phone: 3162624467.
What is Dr. Joseph Moore's NPI?
Dr. Joseph Moore's National Provider Identifier (NPI) is 1750777959, issued by NPPES.
Does Dr. Joseph Moore accept Medicare assignment?
Yes. Dr. Joseph Moore accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Joseph Moore commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, aprepitant, 1 mg (HCPCS J0185). Source: CMS Medicare Physician & Other Practitioners file.